Approval · Notice of Compliance 2354 · 2001
RHOVAIL: Notice of Compliance 2354
Issued March 20, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2354
- Date
- March 20, 2001
- Company
- Rhodiapharm IncLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-inflammatory analgesic agent
Products in this notice
Medicinal ingredients
- KETOPROFEN 150 MG per CAP
- KETOPROFEN 200 MG per CAP